Meyka AI API is live for developers.Start building.
Advertisement
Gelteq Limited Ordinary Shares

Gelteq Limited Ordinary Shares (GELS) Stock Overview

Explore Gelteq Limited Ordinary Shares’s financial performance, market position, analyst ratings, and future outlook.

GELSNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.50
$0.02(3.31%)
U.S. Market opens in 41h 37m
Advertisement

Gelteq Limited Ordinary Shares (GELS)

Meyka AI Score

Z

Key Financials

Market Cap4.6M
P/E Ratio0.00
EPS (TTM)$-0.52
ROE-0.43%
Fundamental Analysis

AI Price Forecasts

1 Month$0.99
3 Months$0.69
1 Year Target$0.00

GELS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Gelteq Limited Ordinary Shares (GELS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.24, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 4.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.31%
5-Day Change
10.44%
1-Month Change
-11.25%
3-Month Change
-37.09%
6-Month Change
-54.40%
Year-to-Date (YTD) Change
-37.88%
1-Year Change
-70.94%
3-Year Change
-83.10%
5-Year Change
-83.10%
All-Time (Max) Change
-83.10%

Contact Information

61 3 9087 3990
641 Glen Huntly Road, Caulfield, VIC, 3162

Company Facts

7 Employees
IPO DateOct 29, 2024
CountryAU
Actively Trading

Frequently Asked Questions